Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02081118
What this trial is testing

Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 209
Testing effectiveness (Phase 2)Study completedNCT01103414
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes
Metabolic Solutions Development Company 356
Not applicableStudy completedNCT03956914
What this trial is testing

Efficacy and Safety of Deep Sea Water on the Blood Glucose Level

Who this might be right for
PreDiabetes
Chonbuk National University Hospital 40
Early research (Phase 1)Study completedNCT01394055
What this trial is testing

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

Who this might be right for
Diabetes Mellitus Type 1 and 2Diabetes Mellitus ComplicationsGastroparesis+1 more
Motus Therapeutics, Inc. 20
Large-scale testing (Phase 3)Study completedNCT01468987
What this trial is testing

A Study in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 1,369
Not applicableLooking for participantsNCT07689214
What this trial is testing

Normast3 for Adults With Diabetic Polyneuropathy

Who this might be right for
Diabete Type 2
University of Roma La Sapienza 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06254014
What this trial is testing

Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients

Who this might be right for
Type 2 Diabetes Mellitus
Beijing Dongfang Biotech Co., Ltd. 270
Large-scale testing (Phase 3)Study completedNCT01676116
What this trial is testing

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 438
Post-approval studies (Phase 4)Study completedNCT01787916
What this trial is testing

52 Week Trial of Liraglutide in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
CHU de Quebec-Universite Laval 15
Large-scale testing (Phase 3)Study completedNCT00327015
What this trial is testing

BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Who this might be right for
Diabetes
AstraZeneca 1,306
Not applicableStudy completedNCT01160991
What this trial is testing

Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism

Who this might be right for
SchizophreniaDiabetesInsulin Resistance
Central Institute of Mental Health, Mannheim 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755150
What this trial is testing

Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Chendu DIAO Pharmaceutical Group CO., LTD. 272
Early research (Phase 1)Study completedNCT02910518
What this trial is testing

Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Type1 Diabetes Mellitus
Sanofi 44
Large-scale testing (Phase 3)Looking for participantsNCT07712913
What this trial is testing

Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia

Who this might be right for
Diabetic NeuropathyNeuropathic PainNeuralgia, Postherpetic
Brainfarma Industria Química e Farmacêutica S/A 348
Early research (Phase 1)Not Yet RecruitingNCT07841860
What this trial is testing

A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple Doses

Who this might be right for
Weight ManagementType 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 122
Large-scale testing (Phase 3)Study completedNCT00113620
What this trial is testing

Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy

Who this might be right for
PainDiabetic Neuropathy
Avanir Pharmaceuticals 450
Testing effectiveness (Phase 2)Study completedNCT01905020
What this trial is testing

Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 28
Not applicableStudy completedNCT03102424
What this trial is testing

Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Taiwan Resonant Waves Research Corporation 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT07288749
What this trial is testing

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Heart Failure (CHF)
Tongji Hospital 1,484
Testing effectiveness (Phase 2)Looking for participantsNCT06647550
What this trial is testing

To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Hyundai Pharm 160
Next Page